Toronto Dominion Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-500
Closed -$93K 1640
2018
Q4
$93K Buy
+500
New +$103K ﹤0.01% 1165

Other funds holding IDXX

Toronto Dominion Bank's IDXX Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Idexx Laboratories (IDXX) stake by 14% in Q1 2026, selling an estimated $2.48M and leaving 24,155 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #540.

Toronto Dominion Bank first reported a position in IDXX in Q2 2016 and has held it in 40 quarters since. The position peaked at $37.9M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Toronto Dominion Bank held 24,155 shares of Idexx Laboratories worth $13.6M as of Q1 2026.
  • Toronto Dominion Bank sold 3,864 Idexx Laboratories shares in Q1 2026, an estimated $2.48M.
  • Idexx Laboratories made up 0.02% of Toronto Dominion Bank's portfolio in Q1 2026, its #540 holding.
  • Toronto Dominion Bank first reported a position in Idexx Laboratories in Q2 2016 and has held it in 40 quarters since.
  • Toronto Dominion Bank's Idexx Laboratories position peaked at $37.9M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.